Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2015 02:17 ET | Source: Esperite N.V.

Esperite (ESP) and Premaitha Health sign a collaboration agreement for NIPT provision in Europe

Manchester, UK and Zutphen, the Netherlands - 16 March 2015 - Premaitha Health plc ("Premaitha", AIM: NIPT) and Esperite NV ("Esperite", AMS: ESP, Zutphen, the Netherlands) today announce the...
March 16, 2015 02:17 ET | Source: Esperite N.V.

Esperite (ESP) et Premaitha Health signent un accord de collaboration pour la réalisation de tests NIPT en Europe

Manchester, Royaume-Uni et Zutphen, Hollande - 16 Mars 2015 - Premaitha Health plc ("Premaitha", AIM: NIPT) et Esperite NV ("Esperite", AMS:ESP, Zutphen, Hollande) annoncent aujourd'hui la signature...
February 23, 2015 11:58 ET | Source: Esperite N.V.

ESPERITE 2,154,000 shares exchanged today. Thank you for your interest in our company

Geneva, Switzerland - 23 February 2015 ESPERITE (ESP) 2'154'000 shares EXCHANGED TODAY. THE COMPANY publishes this note of appreciation addressed to all the investors who massively increased the...
February 23, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (Euronext ESP) pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines CryoSave leads and sponsors a multicentre clinical...
February 23, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (Euronext ESP) ist Pionier bei der weltweit ersten Therapie der Zerebralparese mit 2 Typen von Stammzellen

CryoSave, ein Unternehmen der ESPERITE Gruppe, ist die einzige private Stammzellenbank, die eine klinische Studie nach GCP gemäss dem internationalen GMP-ATMP Standard sponsert CryoSave leitet und...
February 23, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (Euronext ESP) ПРЕДСТАВЯ ЗА ПЪРВИ ПЪТ В СВЕТА КОНЦЕПЦИЯ ЗА ЛЕЧЕНИЕ НА ДЕТСКА ЦЕРЕБРАЛНА ПАРАЛИЗА (ДЦП), ЧРЕЗ ИЗПОЛЗВАНЕ НА 2 ВИДА СТВОЛОВИ КЛЕТКИ

CryoSave, част от групата ESPERITE, инициира и спонсорира мултицентрично клинично проучване, целящо оценка на ефективността от лечението на детска церебрална парализа (ДЦП), чрез вливане на 2 типа...
February 23, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (Euronext ESP): pionnier dans le traitement au niveau mondial de l'Infirmité Motrice Cérébrale (IMC) à base de 2 types de Cellules Souches

CryoSave, entité du groupe ESPERITE, est la seule biobanque privée soutenant un essai clinique selon les Bonnes Pratiques Cliniques conformément aux directives internationales GMP-ATMP CryoSave...
February 23, 2015 01:17 ET | Source: Esperite N.V.

Η EPSERITE (Euronext ESP) πρωτοπορεί με την πρώτη στον κόσμο θεραπευτική αντιμετώπιση για την Εγκεφαλική Παράλυση, με χρήση δύο τύπων βλαστικών κυττάρων

H CryoSave, μέλος του ομίλου ESPERITE, είναι η μοναδική ιδιωτική τράπεζα που χρηματοδοτεί Ορθής Κλινικής Πρακτικής κλινική δοκιμή σύμφωνα με τα διεθνή πρότυπα GMP-ΑΤΜΡ Η CryoSave πρωτοστατεί και...
February 23, 2015 01:17 ET | Source: Esperite N.V.

Az ESPERITE (Euronext ESP) elindítja a világ első olyan Cerebral Palsy (újszülöttkori agykárosodás) kezelését, amely két különböző őssejttípus együttes felhasználásával történik

A CryoSave - az ESPERITE csoport tagja - az egyetlen olyan magán, családi őssejtbank, amely a GMP-ATMP (Good Manufacturing Practices - Advanced Therapy Medicinal Products Regulation) nemzetközi...
February 23, 2015 01:17 ET | Source: Esperite N.V.

ESPERITE (Euronext ESP) apre la strada al primo trattamento al mondo per la Paralisi Cerebrale utilizzando due tipi di cellule staminali

CryoSave, Società del Gruppo ESPERITE, è l'unica biobanca privata che sponsorizza un trial clinico GCP, secondo le linee guida internazionali GMP-ATMP CryoSave conduce e sponsorizza un trial...